ELTX
Elicio Therapeutics Inc.
NASDAQ: ELTX · HEALTHCARE · BIOTECHNOLOGY
$10.62
+2.91% today
Updated 2026-04-30
Market cap
$215.05M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.58
Dividend yield
—
52W range
$5 – $15
Volume
0.1M
Elicio Therapeutics Inc. (ELTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.07M | $1.89M | $-8.02M | $-24.59M | $-22.89M | $-23.94M | $-22.18M | $-32.69M | $-37.07M | $-36.95M |
| Capital expenditures | $47734.00 | $17575.00 | $0.00 | $242000.00 | $41000.00 | $525359.00 | $654000.00 | $66000.00 | $87000.00 | $16000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | $145081.00 | $304468.00 | $617756.00 | $579000.00 | $1.18M | $1.45M | $2.70M |
| Free cash flow | $1.02M | $1.87M | $-8.02M | $-24.83M | $-22.93M | $-24.46M | $-22.83M | $-32.76M | $-37.16M | $-36.97M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — |